The BP-lowering effect of
GABA is due in part to its ability to block peripheral ganglia (Stanton, 1963).
In spontaneously hypertensive rats, GABA has an antihypertensive effect,
possibly through the inhibition of noradrenaline release from sympathetic nerve
endings (Hayakawa
et al,
2002).
In Japan
recently has produced a new type of fermented milk containing GABA by
using two kinds of starters—Lactobacillus
casei strain
Shirota, and
Lactococcus lactis
YIT 2027. The
Lb. casei
strain hydrolyzes milk protein into glutamic acid, and the
Lc. lactis
converts glutamic acid into
GABA (unpublished observation). It has confirmed that this new
fermented milk product has a BP-lowering effect in spontaneously hypertensive
rats (Hayakawa
et al, 2002,
unpublished observation).
The addition of 50-100 mg/bottle of 200 ml milk or yogurt found to produce
relaxation and 20 – 50 mg/200 ml milk or yogurt proved lowering blood pressure
in hypertensive humans.
GABA has many health benefits and now a large dairy company in Japan (Yakult
Dairy Company) has started to launch GABA yogurt. GABA can withstand UHT
treatment and does not affect the taste or flavor of milk.
The
costumer acceptance is very high. In Japan the first batch was 60 000 bottle/day
and now after 2 months increased to 100 000 bottles/day. The targeted customers
were business men and now drivers, sports, students, etc (all who under stress).